A detailed history of Second Half Financial Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Second Half Financial Partners, LLC holds 237 shares of LLY stock, worth $186,801. This represents 0.13% of its overall portfolio holdings.

Number of Shares
237
Holding current value
$186,801
% of portfolio
0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$772.14 - $960.02 $182,997 - $227,524
237 New
237 $209,000
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $33,119 - $38,591
-103 Reduced 1.03%
9,867 $3.61 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $2.96 Million - $3.37 Million
9,970 New
9,970 $3.22 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Second Half Financial Partners, LLC Portfolio

Follow Second Half Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Second Half Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Second Half Financial Partners, LLC with notifications on news.